enGene Therapeutics Inc.
ENGN · XNASCIK 1980845fmd_11GYM23DKG83G0CN0EB7B5NRKZManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Nov 01, 2021 to Jul 31, 2026, 16 periods
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading